Constien; Rainer

Patent Applications and Registrations

Patent applications and USPTO patent grants for Constien; Rainer.The latest application filed is for "novel lipids and compositions for intracellular delivery of biologically active compounds".

Company Profile

0.9.14

Constien; Rainer - Kulmbach DE
Constien; Rainer - Schaftlarn DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lipids and compositions for intracellular delivery of biologically active compounds Grant 9,636,302 - Constien , et al. May 2, 2	2017-05-02
Novel Lipids And Compositions For Intracellular Delivery Of Biologically Active Compounds App 20160324781 - CONSTIEN; Rainer ; et al.	2016-11-10
Lipids and compositions for intracellular delivery of biologically active compounds Grant 9,433,681 - Constien , et al. September 6, 2	2016-09-06
Lipids and compositions for intracellular delivery of biologically active compounds Grant 9,278,130 - Constien , et al. March 8, 2	2016-03-08
Lipids and compositions for intracellular delivery of biologically active compounds Grant 9,149,531 - Constien , et al. October 6, 2	2015-10-06
Novel Lipids And Compositions For Intracellular Delivery Of Biologically Active Compounds App 20150050295 - CONSTIEN; RAINER ; et al.	2015-02-19
Novel Lipids And Compositions For Intracellular Delivery Of Biologically Active Compounds App 20140170175 - CONSTIEN; RAINER ; et al.	2014-06-19
Novel Lipids And Compositions For Intracellular Delivery Of Biologically Active Compounds App 20140162934 - CONSTIEN; Rainer ; et al.	2014-06-12
Novel Lipids And Compositions For Intracellular Delivery Of Biologically Active Compounds App 20140162962 - CONSTIEN; Rainer ; et al.	2014-06-12
Lipids and compositions for intracellular delivery of biologically active compounds Grant 8,691,750 - Constien , et al. April 8, 2	2014-04-08
Novel Lipids and Compositions for Intracellular Delivery of Biologically Active Compounds App 20120295832 - Constien; Rainer ; et al.	2012-11-22
RNAi Modulation of AHA and Therapeutic Uses Thereof App 20120142757 - Constien; Rainer ; et al.	2012-06-07
RNAi Modulation Of TGF-BETA And Therapeutic Uses Thereof App 20120108646 - Vornlocher; Hans-Peter ; et al.	2012-05-03
RNAi modulation of Aha and therapeutic uses thereof Grant 8,114,984 - Constien , et al. February 14, 2	2012-02-14
Compositions And Methods For Inhibiting Expression Of Glucocorticoid Receptor (gcr) Genes App 20110020300 - BAILLY; JACQUES ; et al.	2011-01-27
RNAi Modulation of AHA and Therapeutic Uses Thereof App 20110003882 - Constien; Rainer ; et al.	2011-01-06
RNAi modulation of TGF-beta and therapeutic uses thereof Grant 7,846,908 - Vornlocher , et al. December 7, 2	2010-12-07
RNAi modulation of Aha and therapeutic uses thereof Grant 7,812,150 - Constien , et al. October 12, 2	2010-10-12
Compositions And Methods For Inhibiting Expression Of Ptp1b Genes App 20100197773 - Bramlage; Birgit ; et al.	2010-08-05
Compositions And Methods For Inhibiting Expression Of Factor Vii Genes App 20100124547 - Bramlage; Birgit ; et al.	2010-05-20
RNAi MODULATION OF AHA AND THERAPEUTIC USES THEREOF App 20080113931 - Constien; Rainer ; et al.	2008-05-15
RNAi modulation of TGF-beta and therapeutic uses thereof App 20080015161 - Vornlocher; Hans-Peter ; et al.	2008-01-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.